Intervet/Schering-Plough Animal Health announced that it has shipped 12 million doses of foot-and-mouth disease (FMD) vaccine to South Korea to assist in the country’s efforts to halt the ongoing FMD outbreak. Although the country is gaining ground on controlling the FMD epidemic, the vaccines will be used to further quash the disease from spreading.
Since early January 2011, Intervet/Schering-Plough Animal Health has provided nearly half of all FMD vaccine doses used by the country to control the FMD outbreak. The latest shipment included 12 million doses of DECIVAC® FMD DOE, an inactivated oil-adjuvanted vaccine.
Dr. Klaus Kriebitzsch, Site Director of the FMD facility explains: “Our vaccine site in Cologne has again demonstrated its capability to respond to a short-term demand in an emergency situation by quickly upscaling the production, release and packaging processes of FMD vaccine.”
Paul van Aarle, DVM, Director Institutional Sales at Intervet/Schering-Plough Animal Health adds: “We are extremely proud to have proven once again that we are ready to address emergencies, deliver the required vaccine, meeting agreed quantities and timelines and thereby helping the government of South Korea to battle the current FMD epidemic”.
South Korean officials first confirmed cases of FMD in November 2010. Since then, more than 3 million hogs and cattle have been culled in an effort to quarantine the virus. Country officials started vaccinating all 13 million livestock in the country after initial measures were not effective in controlling the outbreak. Officials also announced the removal of tariffs on 110,000 tons of frozen pork in an effort to keep consumer food prices from inflating.
Source: Intervet/Schering-Plough Animal Health